Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine
- 1 February 2015
- Vol. 33 (8) , 973-976
Abstract
No abstract availableKeywords
Funding Information
- ANR (ANR-11-EMMA-026)
- Agence Nationale pour la Recherche sur le SIDA et les hépatites virales (ANRS) (2014-1)
- Comités de l’Indre et Loire
- Académie Nationale de Médecine
This publication has 15 references indexed in Scilit:
- Hepatitis B virus infectionThe Lancet, 2014
- Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006–2012Clinical Infectious Diseases, 2014
- Bioengineering virus‐like particles as vaccinesBiotechnology and Bioengineering, 2013
- Treatment as prevention and cure towards global eradication of hepatitis C virusTrends in Microbiology, 2013
- Understanding the hepatitis C virus life cycle paves the way for highly effective therapiesNature Medicine, 2013
- Prospects for prophylactic hepatitis C vaccines based on virus-like particlesHuman Vaccines & Immunotherapeutics, 2013
- Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccineHepatology, 2012
- A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in GabonPLOS ONE, 2009
- Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With MenGastroenterology, 2009
- Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccineVaccine, 2003